The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, single-arm, phase II trial of adebrelimab plus nab-paclitaxel and carboplatin in patients with unresectable advanced metastatic or recurrent thymic carcinomas.
 
Ning Xu
No Relationships to Disclose
 
Zhiqiang Gao
No Relationships to Disclose
 
Changlu Wang
No Relationships to Disclose
 
Feng Pan
No Relationships to Disclose
 
Yan Shen
No Relationships to Disclose
 
Lei Zhu
No Relationships to Disclose
 
Jiajia Yuan
Employment - Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China
 
Changhong Zhao
Employment - Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China
 
Zhitao Gu
No Relationships to Disclose
 
Teng Mao
No Relationships to Disclose
 
Wentao Fang
No Relationships to Disclose